QA: Oncocyte Corp in us_medicinal_products/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001642380_2023_Oncocyte_Corp.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001642380, Oncocyte Corp

  xvar xval
0 LiabilitiesNoncurrent 0
1 LiabilitiesCurrent 12,106,000
2 remainder_Liabilities 48,391,000
3 AssetsCurrent 25,536,000
4 AssetsNoncurrent 371,000
5 PropertyPlantAndEquipmentNet 0
6 Goodwill 61,633,000
7 remainder_Assets 12,551,000
8 GeneralAndAdministrativeExpense 23,893,000
9 ResearchAndDevelopmentExpense 7,301,000
10 remainder_Expenses -12,239,000
11 remainder_Revenues 958,000
12 remainder_NetIncome -54,905,000
13 remainder_ComprehensiveNetIncome 2,000
  yvar yval
0 Liabilities 60,497,000
1 Assets 100,091,000
2 Expenses 18,955,000
3 Revenues 958,000
4 StockholdersEquity 39,594,000
5 NetIncome -72,902,000
6 ComprehensiveNetIncome -72,901,000
7 BaseVar 117,704,000
8 EconomicCapitalRatio -0.489

Edgar->Model Mapping

Feature Distribution

Change over Time